Chemomab Therapeutics Ltd.
CMMB· Nasdaq
CMMBChemomab Therapeutics Ltd.
Filed Nov 10, 2022 · 10-Q · 41 days after period end · 0001178913-22-003931
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$8.08M | -$2.97M | -$1.22M | -$7.17M |
| EPS Diluted | $0.04 | $0.01 | $0.01 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemomab Therapeutics Ltd. · CIK 1534248 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 10, 2022 · 41 d after period end
